toya
Not a member
toya's latest activity
Wednesday, March 20 2024
-
toya created the ticket at 3:40 AMAlfa Cytology is a leading custom service provider with experience in pancreatic cancer (PC) basic research. We are now proud to offer a full range of PC basic ...
-
toya created the ticket at 3:37 AMAlfa Cytology can detect specific sequence changes in DNA isolated from brain tumor patient samples (e.g., peripheral blood extracellular vesicles from glioma p...
-
toya created the ticket at 3:26 AMAlfa Cytology can combine RNA-seq data with Whole exome sequencing (WES)to determine whether mutated genes are expressed in tumors. In addition, we can also ana...
-
toya edited the ticket at 3:36 AMAlfa Cytology can combine RNA-seq data with Whole exome sequencing (WES)to determine whether mutated genes are expressed in tumors. In addition, we can also ana...
-
toya edited the ticket at 3:36 AMAlfa Cytology can combine RNA-seq data with Whole exome sequencing (WES)to determine whether mutated genes are expressed in tumors. In addition, we can also ana...
-
toya created the ticket at 3:33 AMAlfa Cytology provides targeted drug therapy in early drug discovery. Targeted drug therapy specifically targets specific abnormalities in cancer cells. By pre...
-
toya edited the ticket at 3:33 AMAlfa Cytology provides targeted drug therapy in early drug discovery. Targeted drug therapy specifically targets specific abnormalities in cancer cells. By pre...
-
toya edited the ticket at 3:33 AMAlfa Cytology provides targeted drug therapy in early drug discovery. Targeted drug therapy specifically targets specific abnormalities in cancer cells. By pre...
-
toya created the ticket at 3:27 AMAlfa Cytology aims to use the patient's immune system to find and destroy brain tumor cells or to help activate the immune system through the patient's dendriti...
-
toya created the ticket at 3:27 AMAlfa Cytology identifies unique cancer-carrying genes by sequencing tumor cell genes, predicts immune presentation affinity, and then screens out unique neoanti...